For a 67-year-old female weighing 71 kg with serum creatinine 0.48 mg/dL and eGFR >90 mL/min, receiving total fluids at 35 mL/h (goal 50 mL/h for 24 h, total 238 g carbohydrate), who took 10 units of NPH insulin at 8 pm last night (insulin‑sensitivity factor 25) and has blood glucose readings of 145 mg/dL at 9 pm, 155 mg/dL at 1 am, and 186 mg/dL at 5 am while continuing the fluid rate today, what should be the NPH insulin dose at 8 am?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

NPH Insulin Dosing for Continuous Tube Feeding

Increase the 8 AM NPH dose to 12-14 units based on the progressive overnight hyperglycemia pattern (145→155→186 mg/dL) and the fact that the patient is receiving continuous carbohydrate load from tube feeding.

Rationale for Dose Adjustment

The patient's blood glucose trajectory shows inadequate overnight coverage despite 10 units NPH at 8 PM:

  • 9 PM: 145 mg/dL (3 hours post-NPH)
  • 1 AM: 155 mg/dL (5 hours post-NPH)
  • 5 AM: 186 mg/dL (9 hours post-NPH)

This rising pattern indicates insufficient insulin coverage during NPH's peak action window (4-6 hours post-injection), which should have occurred around midnight-2 AM 1.

Guideline-Based Approach for Continuous Enteral Feeding

For continuous tube feeding at 35 mL/hr providing carbohydrate load, NPH insulin should be given every 12 hours to provide consistent basal-nutritional coverage 1, 2, 1, 3. The current single evening dose is inadequate.

Recommended Regimen:

Morning dose (8 AM): Start with 12-14 units NPH

  • This represents a 20-40% increase from the evening dose that proved insufficient
  • NPH given in the morning will peak during afternoon/evening hours when tube feeding continues 2, 4, 3

Evening dose (8 PM): Increase to 12-14 units NPH

  • Match the morning dose for consistent 12-hour coverage
  • The previous 10 units was clearly inadequate given the overnight hyperglycemia

Calculation Basis:

The guideline recommendation is 1 unit insulin per 10-15 g carbohydrate for continuous enteral nutrition 1, 2, 5, 1, 3. At 35 mL/hr for 12 hours = 420 mL, which typically contains approximately 140-175 g carbohydrate (depending on formula concentration). This would require 9-17 units per 12-hour period, supporting the 12-14 unit recommendation.

Critical Monitoring Points:

  • Check blood glucose every 4-6 hours while on tube feeding 1
  • Add correctional insulin every 6 hours with regular insulin or every 4 hours with rapid-acting insulin for hyperglycemia 1, 2, 3
  • If tube feeding is interrupted, immediately start 10% dextrose infusion to prevent hypoglycemia, as NPH will continue acting 2, 5, 6, 3
  • Adjust NPH doses daily based on glucose patterns 2, 4, 3

When Tube Feeding Rate Increases to Goal (50 mL/hr):

When advancing to 50 mL/hr (238 g carbohydrate/24 hours = ~119 g per 12 hours), increase each NPH dose proportionally to 16-18 units every 12 hours, following the 1 unit per 10-15 g carbohydrate guideline 1, 2, 3.

Common Pitfall to Avoid:

The most dangerous error is continuing NPH without coordinating with tube feeding status. NPH must never be given without ensuring continuous carbohydrate delivery 2, 5, 6, 3. If tube feeding stops unexpectedly, the long-acting NPH will cause severe hypoglycemia unless dextrose infusion is immediately initiated.

The patient's excellent renal function (eGFR >90) means no dose adjustment for kidney function is needed, and insulin clearance is normal 7.

References

Related Questions

For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?
What does a basal insulin level of 2.3 (microunits per milliliter) indicate in a 48-year-old man with no known diabetes?
In a 27‑year‑old woman with type 2 diabetes, weight 86.6 kg, creatinine 0.40 mg/dL, GFR > 90 mL/min, currently taking neutral protamine Hagedorn (NPH) insulin 32 U at 8 am, dexamethasone 20 mg daily, with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 3 g carbohydrate and an insulin sensitivity factor (ISF) of 25 mg/dL per U, and blood glucose values of 207 mg/dL at 9 am, 229 mg/dL after a 90‑g carbohydrate meal, 373 mg/dL at 5 pm, 340 mg/dL at 9 pm, and 286 mg/dL at 2 am, what should the NPH basal insulin dose, ISF, and ICR be adjusted to?
A 28‑week‑gestation pregnant woman weighing 114 kg has a fasting blood glucose of 157 mg/dL while on insulin glargine (Lantus) 40 units daily; how much should the insulin glargine dose be increased?
How should a 19‑year‑old female with a family history of diabetes, normal fasting glucose (88 mg/dL) and HbA1c (5.2 %), but elevated fasting insulin (47.3 µU/mL) be managed?
What are the recommended psychosocial and pharmacologic treatments for an adult who wants to stop using marijuana, including management of withdrawal symptoms?
In a 75-year-old man receiving testosterone replacement therapy (200 mg testosterone enanthate every two weeks) with free testosterone 203 pg/mL, total testosterone 889 ng/dL, and estradiol 43 pg/mL, what further workup and treatment adjustments are recommended?
What is the recommended first-line medication for nausea?
Can worsening chronic kidney disease lead to pulmonary hypertension?
How can arterial plaques be identified?
How does risperidone affect weight and what monitoring and management strategies are recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.